Sort by:

• Highly Influential Citations
• Citations
• Acceleration
• Velocity
• Recency

Learn More

Collagen type II C-telopeptide fragments as an index of cartilage degradation.

• Stephan Christgau, Patrick Garnero, +5 authors Per Qvist
• Bone
• 2001

We report the development of an assay for measurement of the urinary concentration of collagen type II C-telopeptide fragments. This assay was developed for providing a specific marker of joint… (More)

Predicting treatment choice for patients with pelvic organ prolapse.

• Michael H. Heit, Chris Rosenquist, Patrick J. Culligan, Carol A. Graham, Miles Murphy, Susan B Shott
• Obstetrics and gynecology
• 2003

OBJECTIVE To evaluate which clinical factors were predictive of treatment choice for patients with pelvic organ prolapse. METHODS One hundred fifty-two patients were enrolled in this… (More)

Is pelvic organ prolapse a cause of pelvic or low back pain?

• Michael H. Heit, Patrick J. Culligan, Chris Rosenquist, Susan B Shott
• Obstetrics and gynecology
• 2002

OBJECTIVE To test the null hypothesis that there is no association between pelvic organ prolapse and pelvic or low back pain. METHODS A total of 152 consecutive patients with pelvic organ prolapse… (More)

Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen.

• Chris Rosenquist, Christian Fledelius, +4 authors Claus Christiansen
• Clinical chemistry
• 1998

We have developed a two-site ELISA for measurement in serum of bone-related degradation products derived from C-terminal telopeptides of type I collagen. The assay is based on the application of two… (More)

Tibolone: prevention of bone loss in late postmenopausal women.

• Nina Hannover Bjarnason, Ketil Bjarnason, Jens Haarbo, Chris Rosenquist, Claus Christiansen
• The Journal of clinical endocrinology and…
• 1996

The aim of the study was to assess the effects of 2 yr of treatment with two dose levels of tibolone on bone mineral density and bio-chemical markers of bone metabolism in late postmenopause.… (More)

Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies.

• Chris Rosenquist, Per Qvist, Nina Hannover Bjarnason, Claus Christiansen
• Clinical chemistry
• 1995

Intact human osteocalcin purified from femoral bones as well as tryptic fragments of the intact molecule [amino acids (aa) 1-19, 20-43, and 45-49] were used to raise and screen monoclonal antibodies… (More)

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

• Stephan Christgau, Chris Rosenquist, +6 authors Claus Christiansen
• Clinical chemistry
• 1998

The Serum CrossLaps One Step ELISA is a sandwich assay using two monoclonal antibodies specific for a beta-aspartate form of the epitope EKAHDGGR derived from the carboxy-terminal telopeptide region… (More)

High bone turnover is associated with low bone mass in both pre- and postmenopausal women.

• Pernille Ravn, Christian Fledelius, Chris Rosenquist, Kirsten Overgaard, Claus Christiansen
• Bone
• 1996

In 979 healthy women, aged 30-75 years, bone mass was measured by DXA in the lumbar spine and proximal femur, and by SXA in the distal forearm. Bone turnover was assessed by urinary CrossLaps… (More)

A simple enzyme-linked immunosorbent assay of human osteocalcin.

• Chris Rosenquist, Marianne Bonde, Christian Fledelius, Per Qvist
• Clinical chemistry
• 1994

A heterologous ELISA for measurement of osteocalcin (bone Gla-protein) is described, involving biotinylated bovine osteocalcin and polyclonal antibodies. The log-linear range was 2.3-37.5… (More)

Effect of drift of 2, 4-d spray on irish potatoes

• Chris Rosenquist
• 2008

• ‹
• 1
• 2
• ›